U.S. biotech company to lay off nearly one third of American staff


  • World
  • Thursday, 20 Jul 2023

SAN FRANCISCO, July 19 (Xinhua) -- U.S. biotech company FibroGen will lay off 104 workers, nearly a third of its U.S. employees, the company announced on Wednesday.

FibroGen, which is based in San Francisco, California, said it would reduce about 32 percent of its U.S. workforce and save 30 million to 35 million U.S. dollars in annual expenses in the future.

The company expects 13 million to 15 million dollars in charges related to the layoffs, including severance pay and employee benefits, according to a corporate filing.

FibroGen shares plunged by more than 85 percent in the past month and were down about 7 percent on Wednesday. The company's market capitalization is now 232 million dollars.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In World

Trump says he picks Bessent to be US treasury secretary
Disabled Americans rely on rideshare apps but say they still face discrimination: AP
U.S. private-sector activity picks up pace as firms look forward to new gov't: survey
NYC congestion pricing plan to start in January
Spain's solar power poised to surpass wind power as top renewable energy source
U.S. stocks close higher
Mpox still public health emergency: WHO
3rd Wine Vision fair opens in Belgrade
Crude futures settle higher
Bolsonaro's coup indictment postponed by Brazil's top prosecutor, sources say

Others Also Read